1
|
Alvarez-Alonso MJ, Jurado-Barba R, Martinez-Martin N, Espin-Jaime JC, Bolaños-Porrero C, Ordoñez-Franco A, Rodriguez-Lopez JA, Lora-Pablos D, de la Cruz-Bértolo J, Jimenez-Arriero MA, Manzanares J, Rubio G. Association between maltreatment and polydrug use among adolescents. Child Abuse Negl 2016; 51:379-89. [PMID: 26318780 DOI: 10.1016/j.chiabu.2015.07.014] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/09/2015] [Revised: 07/14/2015] [Accepted: 07/30/2015] [Indexed: 05/16/2023]
Abstract
Different studies have related sexual and physical abuse during childhood and adolescence to the development of substance abuse disorders. Nevertheless, we are not aware of the role that other more common maltreatment types, such as neglect, will play among the most risky pattern of consumption: the polydrug use. A clinical sample of 655 adolescents, divided into two groups: polydrug users and non-polydrug users, were assessed on their pattern of drug consumption, history of childhood maltreatment, current psychopathology and their family history of alcoholism. Polydrug users had a greater prevalence of all types of maltreatment, although the most associated to this group were sexual abuse and emotional neglect. Other relevant variables to adolescent consumption were: the diagnosis of depressive disorder, the presence of anxiety traits and the family history of alcohol dependence. Polydrug users have higher risks of having had problems during infancy and adolescence, such as maltreatment and other psychopathological conditions, with the addition of family history of alcoholism. Accordingly, practitioners should take into account that those variables may influence polydrug abuse because it is the most risky pattern for subsequent dependence of substances, and they should always be considered during treatment.
Collapse
Affiliation(s)
- M J Alvarez-Alonso
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain
| | - R Jurado-Barba
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain; Complutense University, Av. Séneca 2, 28040 Madrid, Spain; Camilo José Cela University, Castillo de Alarcón, 49, Villafranca del Castillo, 28692 Madrid, Spain
| | - N Martinez-Martin
- 12 de Octubre University Hospital, Av. Cordoba s/n, 28041 Madrid, Spain
| | - J C Espin-Jaime
- 12 de Octubre University Hospital, Av. Cordoba s/n, 28041 Madrid, Spain
| | - C Bolaños-Porrero
- Addictions Institute "Madrid Salud", Madrid City Hall, Juan Esplandiú 11, 28007, Spain
| | - A Ordoñez-Franco
- Addictions Institute "Madrid Salud", Madrid City Hall, Juan Esplandiú 11, 28007, Spain
| | - J A Rodriguez-Lopez
- Addictions Institute "Madrid Salud", Madrid City Hall, Juan Esplandiú 11, 28007, Spain
| | - D Lora-Pablos
- Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain
| | - J de la Cruz-Bértolo
- Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain
| | - M A Jimenez-Arriero
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain; Complutense University, Av. Séneca 2, 28040 Madrid, Spain; Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental, CIBERSAM, Monforte de Lemos 3-5, 28029 Madrid, Spain
| | - J Manzanares
- Networks for Cooperative Research in Health (RETICS-Addictive Disorder Network), Institute of Health Carlos III (ISCIII), MICINN and FEDER, Madrid, Spain; Neurosciences Institute, Universidad Miguel Hernández, Campus San Juan, Alicante, Spain
| | - G Rubio
- Hospital 12 de Octubre" i+12 Research Institute, Av. Cordoba s/n, 28041 Madrid, Spain; Complutense University, Av. Séneca 2, 28040 Madrid, Spain; Clinical Research Unit, I+12-CIBERESP, Hospital 12 de Octubre, Av. Cordoba s/n, 28041 Madrid, Spain; Networks for Cooperative Research in Health (RETICS-Addictive Disorder Network), Institute of Health Carlos III (ISCIII), MICINN and FEDER, Madrid, Spain
| |
Collapse
|